Actionable news
All posts from Actionable news
Actionable news in ETRM: EnteroMedics Inc.,

Ionis to seek inotersen approval without Glaxo; EnteroMedics ETRM offering - shares slide 40%

Price and Volume Movers

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced that GlaxoSmithKline (NYSE: GSK) will no longer support development of inotersen and IONIS-FB-LRx with Ionis retained all rights to both pipeline candidates. Ionis plans to file for marketing authorization for inotersen for the treatment of TTR amyloidosis later this year.

Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) announced that it has reduced its overall workforce by 20% as part of its restructuring program to reduce costs. It expects the workforce reductions to result in savings of between $3.7m-$4.3m in fiscal year...